Skip to main content

Table 1 Number of viral and non-viral HCC patients and ratios/ year

From: Serum anti-P53 antibodies and alpha-fetoprotein in patients with non-B non-C hepatocellular carcinoma

Number in Years

Viral (HCV, HBV and co-infect.)

Non-B non-C

Total

- First year

74 (C: 57, B: 10, C&B: 7) =30.58%

5 =12.82%

79 =28.11%

- Second year

83 (C: 62, B: 10, C&B:11) =34.30%

10 =25.64%

93 =33.10%

- Third year

85 (C: 67, B: 6, C&B:12) =35.12%

24 = 61.54%

109 =37.79%

Total in 3 years

242 (C: 186, B: 26, C&B:30) = 100%

39 = 100%

281 = 100%

  1. There is insignificant increase in number of total HCC, viral, non-viral HCC patients when comparing between first, second and third year (P-Value >0.05).